CEO: | Anders Lundstrom |
Independent Non-Executive Director: | Fabiana Lacerca Allen |
Independent Non-Executive Director: | Peter Llewellyn-Davies |
Non-Executive Chairman: | Hans-Peter Hasler |
Non-Executive Dir: | Christian Schweiger |
Address: | Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF |
Phone: | +44 (0) 191 511 8500 |
Website: | http://www.shieldtherapeutics.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BYV81293 |
Currency | UK Pounds |
Share Price | 7.85p |
Change Today | 0.050p |
% Change | 0.64 % |
52 Week High | 9.00 |
52 Week Low | 2.25 |
Volume | 711,198 |
Shares Issued | 1,061.80m |
Market Cap | £83.35m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
15:49 | 1,333 @ 7.80p |
15:34 | 9,650 @ 7.82p |
15:30 | 53,494 @ 7.84p |
15:14 | 3,617 @ 8.10p |
14:40 | 82,025 @ 8.10p |
You are here: research